Triple Assessment of Breast Lumps The Efficacy for the Detection of Breast Cancer Disease in Iraqi Females Mahdi Jasim Moosa* CABS, Sarmad Abdul Wahhab Hussein* MBChB
Abstract
ABSTRACT Background: Breast is the most site-specific cancer in women; it is the leading cause of death from cancer in women aged 20-59 years. It account for 26% of all newly diagnosed cancer in women and responsible for 15% of cancer related death in women.
Objective: To evaluate the efficiency of triple assessment {Clinical examination (C/E), imaging technique and Fine needle aspiration cytology (FNAC)} of breast lumps for the detection of breast cancer disease in Iraqi females presenting to the breast clinic and apply the results obtained in the proper management of breast pathology
Methods: A case series study carried out at Al-Yarmouk Teaching Hospital during the period from 1st July 2011 to 31st December 2012, in which a selected sample of 156 patients was studied. The study includes female patients that attend the breast clinic in AlYarmouk Teaching Hospital and were followed to have the last conclusive results of histopathology.
Result: There were 117 (75%) benign lesions and 39 (25%) malignant lesions. The sensitivity of C/E was 79.5% and specificity 89.7%, and that For U/S were 89.7% and 96.6%, and for Mammography were 87.2% and 95.7% respectively; while that of FNAC were 92.3% and 98.3% respectively and the sensitivity of triple assessment was 94.9% and specificity was 100%
Conclusion: The triple assessment is a sensitive, specific, accurate, simple, easy, fast, minimally invasive and a low-cost assessment system that can be applied in the initial breast clinic visit reaching the diagnosis in comparison to the final diagnosis with the histopathology
Copyright (c) 2017 Iraqi Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Share — copy and redistribute the material in any medium or format
Under the following terms:
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
-
NonCommercial — You may not use the material for commercial purposes.
-
NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
